Amantadine

This is a medication used to treat the flu and some movement disorders like Parkinson's disease. It works by affecting chemicals in the brain.

Brand names:Symadine, Symmetrel
Medication

What people taking Amantadine report

Every report comes from a Lived member, sent anonymously.

Have you tried Amantadine for Parkinson's Disease?

NameHow it went

About Amantadine

What It's For

Amantadine is a prescription medicine taken by mouth, used today mainly for Parkinson's disease. It helps with two different problems in that condition. After some years of treatment, levodopa (the main Parkinson's medicine) can cause dyskinesia: involuntary writhing, twisting or jerking movements that rise and fall with each dose. Amantadine is one of the few medicines shown to reduce them. It can also ease the stiffness, slowness and tremor of Parkinson's itself, although it is less effective than levodopa for those symptoms. Immediate-release amantadine is also approved for movement side effects caused by certain other medicines, known as drug-induced extrapyramidal reactions. Gocovri is an extended-release capsule approved specifically for dyskinesia in people taking levodopa, and as an add-on to levodopa/carbidopa for "off" episodes, the times when Parkinson's symptoms return before the next dose is due. Generic immediate-release capsules, tablets and liquid are the older, more widely used form. The original brand, Symmetrel, and another extended-release tablet, Osmolex ER, are no longer sold in the US. Amantadine was first developed as an antiviral against influenza A, and that use remains on its label. However, most flu viruses now circulating are resistant to it, so infectious disease guidelines recommend other flu antivirals, such as oseltamivir, instead. Specialists sometimes use it off-label after a severe traumatic brain injury, where a neurology guideline supports it to speed early recovery in adults with reduced consciousness.

How It Works

Researchers do not fully know how amantadine improves Parkinson's symptoms or dyskinesia. It has more than one action in the brain. It weakly blocks NMDA (N-methyl-D-aspartate) receptors, the docking sites for glutamate, a chemical messenger that excites nerve cells. It also appears to strengthen the activity of dopamine, the messenger that declines in Parkinson's disease. Which of these effects matters most for its benefit is not settled. The same actions help explain its side effects. Its influence on dopamine is linked to hallucinations and dizziness, and it causes dry mouth, constipation and difficulty passing urine, similar to drugs that block the messenger acetylcholine. Against influenza A, it interferes with the virus's ability to spread in the body, but only for virus strains that have not become resistant.

Dosage & Administration

Immediate-release amantadine comes as capsules, tablets and a liquid, usually taken once or twice a day. For Parkinson's disease, a common adult regimen is 100 mg twice a day, often starting at 100 mg once a day for people with other serious illnesses or who already take high doses of other Parkinson's medicines. Gocovri is taken once a day at bedtime, with a lower starting dose for the first week. The capsule is swallowed whole and should not be crushed, chewed or divided; if swallowing is hard, the contents can be sprinkled on a spoonful of soft food such as applesauce and swallowed right away without chewing. Gocovri is not interchangeable with other amantadine products, so switching between them needs a new plan from the prescriber. If a Gocovri dose is missed, the next one is taken at the usual time. The kidneys clear amantadine from the body, so the dose is lowered for people with reduced kidney function, and often for people 65 and older. A blood test of kidney function guides the right dose. Do not stop amantadine suddenly. Abrupt stopping can make Parkinson's symptoms worsen sharply and can bring on confusion, agitation or hallucinations. Rarely it triggers a dangerous reaction with high fever, severe muscle stiffness and confusion or reduced alertness, which needs emergency care. When stopping is planned, the prescriber usually lowers the dose gradually first.

Side Effects

Dizziness or lightheadedness (especially when standing up), nausea, dry mouth, constipation, trouble sleeping and swelling of the ankles are among the most common effects. In Gocovri's trials, dizziness, drops in blood pressure on standing and falls were all more frequent than with placebo. Some people develop livedo reticularis, a lacy, purplish mottling of the skin, usually on the legs. Hallucinations are the side effect most likely to change treatment. In Gocovri's trials in people with Parkinson's disease, about one in four had hallucinations, paranoia or similar experiences, compared with 3% on placebo, and some stopped the medicine because of them. They are most likely after starting or increasing the dose. Some less common effects need prompt contact with the prescriber. New blurred vision or vision loss, with or without eye pain, can be swelling of the cornea (the clear front surface of the eye), which can become permanent if amantadine is continued. Depression or thoughts of suicide have been reported, including during short courses. Some people develop intense urges to gamble, spend money, binge eat or have sex, and may not recognize the change themselves, so observations from family members matter. Falling asleep without warning during everyday activities, such as eating or driving, is a reason to stop driving and call the care team.

Interactions & Warnings

Medicines with anticholinergic effects (drugs that block acetylcholine and cause dry mouth, constipation or confusion) can add to the same side effects of amantadine, so a pharmacist should review the full medicine list. Alcohol is best avoided because it increases dizziness, confusion and drops in blood pressure. Some medicines raise amantadine levels, including quinine or quinidine (used for malaria or heart rhythm) and the diuretic combination triamterene/hydrochlorothiazide. Substances that make urine more alkaline, such as sodium bicarbonate, can also lead to buildup. Amantadine can stop the nasal-spray live flu vaccine from working; injected flu shots can be given as usual. Amantadine needs particular care, or may be unsuitable, for people with kidney disease (deaths from buildup have occurred when doses were too high for kidney function, and Gocovri is not used in kidney failure), untreated angle-closure glaucoma, a seizure disorder, heart failure, a psychotic illness, or a history of depression or suicidal thoughts. Human data in pregnancy are limited and animal studies showed birth defects at high doses, so anyone pregnant or planning pregnancy should weigh alternatives with the prescriber. An overdose can be fatal, affecting heart rhythm, breathing, the kidneys and the brain; as little as 1 gram (ten 100 mg capsules) has caused death. If someone may have taken too much, get emergency medical help right away. Keep the medicine out of reach of others in the household.

What to Expect

Immediate-release amantadine often begins to help Parkinson's symptoms within about two days. Gocovri's effect on dyskinesia was measured after about 12 weeks in trials, by which point people had more "on" time without troublesome movements and less "off" time. Benefit varies: some people notice a clear reduction in dyskinesia, while others find the side effects outweigh it. The benefit of immediate-release amantadine sometimes fades after a few months. The prescriber may then adjust the dose, pause the medicine for a few weeks and restart it, or rely more on other Parkinson's treatments. As movement improves, physical activity is best increased gradually. Follow-up visits usually check for hallucinations, mood changes, dizziness and falls, ankle swelling and any change in vision, and kidney function is rechecked over time since it determines a safe dose. Any decision to stop is best planned with the prescriber so the dose can be tapered.

Questions to Ask Your Doctor

  1. 1.Is amantadine mainly meant to reduce my dyskinesia, my other Parkinson's symptoms, or both, and how will we tell if it is working?
  2. 2.Should I take immediate-release amantadine or Gocovri, and what are the differences in cost, dosing and side effects for me?
  3. 3.Does my kidney function or age mean I need a lower dose, and how often will it be checked?
  4. 4.Which hallucinations, mood changes or vision problems should prompt a call, and what should my family watch for?
  5. 5.If I need to stop amantadine, how would we taper it safely?

Last reviewed • Oct 2026

Educational content, not medical advice.